BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30787250)

  • 1. Estimation of Gadolinium-based Contrast Agent Concentration Using Quantitative Synthetic MRI and Its Application to Brain Metastases: A Feasibility Study.
    Fujita S; Nakazawa M; Hagiwara A; Ueda R; Horita M; Maekawa T; Irie R; Andica C; Kunishima Kumamaru K; Hori M; Aoki S
    Magn Reson Med Sci; 2019 Oct; 18(4):260-264. PubMed ID: 30787250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis.
    He D; Chatterjee A; Fan X; Wang S; Eggener S; Yousuf A; Antic T; Oto A; Karczmar GS
    Invest Radiol; 2018 Oct; 53(10):609-615. PubMed ID: 29702525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detectability of small liver metastases with gadolinium BOPTA.
    Runge VM; Lee C; Williams NM
    Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Pharmacokinetic, Pharmacodynamic Profile, and Tolerance of Gadopiclenol, A New High Relaxivity GBCA, in Healthy Subjects and Patients With Brain Lesions (Phase I/IIa Study).
    Hao J; Bourrinet P; Desché P
    Invest Radiol; 2019 Jul; 54(7):396-402. PubMed ID: 30870257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed Gadolinium-enhanced MR Imaging of Cartilage: A Comparative Analysis of Different Gadolinium-based Contrast Agents in an ex Vivo Porcine Model.
    Kang Y; Choi JY; Yoo HJ; Hong SH; Kang HS
    Radiology; 2017 Mar; 282(3):734-742. PubMed ID: 27649101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observed Deposition of Gadolinium in Bone Using a New Noninvasive in Vivo Biomedical Device: Results of a Small Pilot Feasibility Study.
    Lord ML; Chettle DR; Gräfe JL; Noseworthy MD; McNeill FE
    Radiology; 2018 Apr; 287(1):96-103. PubMed ID: 29237148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of metal ion and formulation concentration for first-pass brain perfusion studies with magnetic resonance imaging at 1.5 tesla.
    Runge VM; Wells JW
    Invest Radiol; 1996 Jul; 31(7):395-400. PubMed ID: 8818779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
    Li Y; Liu G; Lou X; Chen Z; Ma L
    Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Virtual Contrast Enhancement in Brain MRI Replace Gadolinium?: A Feasibility Study.
    Kleesiek J; Morshuis JN; Isensee F; Deike-Hofmann K; Paech D; Kickingereder P; Köthe U; Rother C; Forsting M; Wick W; Bendszus M; Schlemmer HP; Radbruch A
    Invest Radiol; 2019 Oct; 54(10):653-660. PubMed ID: 31261293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of Contrast Agent Concentration in DCE-MRI Using 2 Flip Angles.
    Bharadwaj Das A; Tranos JA; Zhang J; Zaim Wadghiri Y; Kim SG
    Invest Radiol; 2022 May; 57(5):343-351. PubMed ID: 35025833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of gadolinium Cy2DOTA, a new hepatobiliary agent, and gadolinium HP-DO3A, an extracellular agent, in healthy liver and metastatic disease.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1995 Feb; 30(2):123-30. PubMed ID: 7782188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of gadolinium deposition in dentate nucleus using quantitative susceptibility mapping.
    Hinoda T; Fushimi Y; Okada T; Arakawa Y; Liu C; Yamamoto A; Okada T; Yoshida K; Miyamoto S; Togashi K
    J Magn Reson Imaging; 2017 May; 45(5):1352-1358. PubMed ID: 27664936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of concentration and dilution of three macrocyclic gadolinium-based contrast agents on MRI signal intensity at 1.5T and 3T and different pulse sequences: results of a phantom study in human plasma.
    Szomolanyi P; Frenzel T; Noebauer-Huhmann IM; Rohrer M; Trattnig S; Pietsch H; Endrikat J
    Acta Radiol; 2021 Jan; 62(1):51-57. PubMed ID: 32290676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple method for quantification of gadolinium magnetic resonance imaging contrast agents using ESR spectroscopy.
    Takeshita K; Kinoshita S; Okazaki S
    Chem Pharm Bull (Tokyo); 2012; 60(1):31-6. PubMed ID: 22223372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.
    Kanda T; Osawa M; Oba H; Toyoda K; Kotoku J; Haruyama T; Takeshita K; Furui S
    Radiology; 2015 Jun; 275(3):803-9. PubMed ID: 25633504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue.
    Jost G; Frenzel T; Lohrke J; Lenhard DC; Naganawa S; Pietsch H
    Eur Radiol; 2017 Jul; 27(7):2877-2885. PubMed ID: 27832312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.